232 related articles for article (PubMed ID: 24947855)
1. Pharmacological treatment for common prostatic conditions in dogs - benign prostatic hyperplasia and prostatitis: an update.
Niżański W; Levy X; Ochota M; Pasikowska J
Reprod Domest Anim; 2014 Jun; 49 Suppl 2():8-15. PubMed ID: 24947855
[TBL] [Abstract][Full Text] [Related]
2. The effects of osaterone acetate on clinical signs and prostate volume in dogs with benign prostatic hyperplasia.
Socha P; Zduńczyk S; Tobolski D; Janowski T
Pol J Vet Sci; 2018 Dec; 21(4):559-566. PubMed ID: 30605276
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of techniques for diagnosis of canine prostatic diseases.
Barsanti JA; Finco DR
J Am Vet Med Assoc; 1984 Jul; 185(2):198-200. PubMed ID: 6204960
[TBL] [Abstract][Full Text] [Related]
4. Theriogenology question of the month. Benign prostatic hypertrophy (BPH), prostatitis, and prostatic neoplasia.
Root Kustritz M; Merkel L
J Am Vet Med Assoc; 1998 Sep; 213(6):807-9. PubMed ID: 9743718
[No Abstract] [Full Text] [Related]
5. Regression of prostatic hypertrophy by osaterone acetate in dogs.
Tsutsu T; Hori T; Shimizu M; Orima H; Kawakami E; Fukuda S
J Vet Med Sci; 2000 Oct; 62(10):1115-9. PubMed ID: 11073087
[TBL] [Abstract][Full Text] [Related]
6. [Diseases of the prostate in the dog].
Arbeiter K
Tierarztl Prax; 1987; 15(3):291-4. PubMed ID: 2447680
[TBL] [Abstract][Full Text] [Related]
7. Efficacies of osaterone and delmadinone in the treatment of benign prostatic hyperplasia in dogs.
Albouy M; Sanquer A; Maynard L; Eun HM
Vet Rec; 2008 Aug; 163(6):179-83. PubMed ID: 18689779
[TBL] [Abstract][Full Text] [Related]
8. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
9. Effect of osaterone acetate administration on prostatic regression rate, peripheral blood hormone levels and semen quality in dogs with benign prostatic hypertrophy.
Tsutsui T; Hori T; Shimizu M; Tatsuzawa C; Kawakami E
J Vet Med Sci; 2001 Apr; 63(4):453-6. PubMed ID: 11346183
[TBL] [Abstract][Full Text] [Related]
10. Benign prostatic hyperplasia in the dog.
Cunto M; Ballotta G; Zambelli D
Anim Reprod Sci; 2022 Dec; 247():107096. PubMed ID: 36279818
[TBL] [Abstract][Full Text] [Related]
11. [Benign prostatic hyperplasia: treatment options in the dog].
Renggli M; Padrutt I; Michel E; Reichler I
Schweiz Arch Tierheilkd; 2010 Jun; 152(6):279-84. PubMed ID: 20533201
[TBL] [Abstract][Full Text] [Related]
12. Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in prostatic disorders in dogs.
Weinekötter J; Gurtner C; Protschka M; von Bomhard W; Böttcher D; Alber G; Kiefer I; Steiner JM; Seeger J; Heilmann RM
BMC Vet Res; 2023 Nov; 19(1):234. PubMed ID: 37946179
[TBL] [Abstract][Full Text] [Related]
13. Effects of benign prostatic hyperplasia and finasteride therapy on prostatic blood flow in dogs.
Angrimani DSR; Silvestrini GR; Brito MM; Abreu RA; Almeida LL; Vannucchi CI
Theriogenology; 2018 Jul; 114():103-108. PubMed ID: 29605575
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study.
Shafiee R; Shariat A; Khalili S; Malayeri HZ; Mokarizadeh A; Anissian A; Ahmadi MR; Hosseini E; Naderafif M; Mohsenzadeh S; Rasoulian MH; Rezapour R; Pourzaer M
Tumour Biol; 2015 Apr; 36(4):2437-45. PubMed ID: 25420908
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the clinical efficacy of Gonazon implants in the treatment of reproductive pathologies, behavioral problems, and suppression of reproductive function in the male dog.
Goericke-Pesch S; Wilhelm E; Ludwig C; Desmoulins PO; Driancourt MA; Hoffmann B
Theriogenology; 2010 Apr; 73(7):920-6. PubMed ID: 20097413
[TBL] [Abstract][Full Text] [Related]
16. Canine Prostate Disease.
Christensen BW
Vet Clin North Am Small Anim Pract; 2018 Jul; 48(4):701-719. PubMed ID: 29933768
[TBL] [Abstract][Full Text] [Related]
17. [Benign prostate hyperplasia with chronic prostatitis: an update].
Ma Y; Zhang WL
Zhonghua Nan Ke Xue; 2010 Jul; 16(7):646-50. PubMed ID: 20873602
[TBL] [Abstract][Full Text] [Related]
18. [Penetrability and therapeutic effect of vancomycin to the prostates of rats with bacterial prostatitis (BP) or BPH-BP].
Wang H; Chen ZH; Zhu YY; Wang T; Wu XJ
Zhonghua Nan Ke Xue; 2006 Jun; 12(6):490-5. PubMed ID: 16833184
[TBL] [Abstract][Full Text] [Related]
19. Role of 5α-reductase inhibitors in benign prostatic diseases.
Azzouni F; Mohler J
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):222-30. PubMed ID: 22333687
[TBL] [Abstract][Full Text] [Related]
20. Study of prostatic disease in dogs: 177 cases (1981-1986).
Krawiec DR; Heflin D
J Am Vet Med Assoc; 1992 Apr; 200(8):1119-22. PubMed ID: 1376729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
